Key Takeaways
- •Specialty & Focus：Advanced Clinic — specializing in ABeVax® multivalent DC vaccine, WT1/NY-ESO-1/MAGE-A3 peptides, NK cell combination
- •Core Features：Multivalent dendritic-cell vaccine and ABeVax technical background, Activated NK/NKT/gamma-delta T-cell therapy consultation
- •Location：Located in Chiyoda-ku, Tokyo
- •Coordination Relationship：Case-by-case coordination
About This Hospital
Tokyo Cancer Clinic is located in Iidabashi, Chiyoda-ku. Its current official site focuses on multivalent dendritic-cell vaccines, activated NK-cell therapy, activated NK/NKT/gamma-delta T-cell therapy, immune adjuvant care, and supportive care. ABeVax, long-chain peptide, low-volume blood draw, and patent information can be treated as technical background, but patient-facing copy should frame these services as self-pay cancer immunotherapy consultations requiring case-by-case physician review.
Medical Features & Strengths
- Multivalent dendritic-cell vaccine and ABeVax technical background
- Activated NK/NKT/gamma-delta T-cell therapy consultation
- Supportive therapy and supportive-care assessment
- Foreign patients require medical-coordinator confirmation
- Appointment-only clinic near Kudanshita and Iidabashi
- Current physicians and founder background should be described separately
Departments & Specialties
Public Doctor Profiles
These profiles are shown only when public photos and profile data are already available. The attending physician, schedule, and acceptance conditions must still be confirmed with the clinic.
Abe Hiroyuki
Chairperson
Tokyo Cancer Clinic
Sasada Amako
Director
Tokyo Cancer Clinic
Detailed Information
Tokyo Cancer Clinic presents multivalent dendritic-cell vaccine therapy, ABeVax and immune-cell related services. This page describes them as officially published self-pay consultation options requiring review of patient records.
Relevant topics include multivalent dendritic-cell vaccine, ABeVax, NK/NKT/gamma-delta T cell related therapy and supportive therapy. Patients should prepare pathology, imaging, treatment history, medication and laboratory data before feasibility inquiry.
Clinic positioning
Relevant topics include multivalent dendritic-cell vaccine, ABeVax, NK/NKT/gamma-delta T cell related therapy and supportive therapy. Patients should prepare pathology, imaging, treatment history, medication and laboratory data before feasibility inquiry.
Multivalent dendritic-cell vaccine and ABeVax®
Relevant topics include multivalent dendritic-cell vaccine, ABeVax, NK/NKT/gamma-delta T cell related therapy and supportive therapy. Patients should prepare pathology, imaging, treatment history, medication and laboratory data before feasibility inquiry.
If standard treatment remains indicated, this page should not encourage delaying or stopping it. Discussion should start from the existing medical record, the treating physician's plan, imaging and the patient's general condition.
NK / NKT / gamma-delta T cell related therapy
Relevant topics include multivalent dendritic-cell vaccine, ABeVax, NK/NKT/gamma-delta T cell related therapy and supportive therapy. Patients should prepare pathology, imaging, treatment history, medication and laboratory data before feasibility inquiry.
If standard treatment remains indicated, this page should not encourage delaying or stopping it. Discussion should start from the existing medical record, the treating physician's plan, imaging and the patient's general condition.
Supportive therapy and integrated care
Relevant topics include multivalent dendritic-cell vaccine, ABeVax, NK/NKT/gamma-delta T cell related therapy and supportive therapy. Patients should prepare pathology, imaging, treatment history, medication and laboratory data before feasibility inquiry.
Doctors and team information
Foreign-patient arrangements, interpreter requirements, appointment route, treatment schedule and total self-pay cost must be confirmed before travel.
Foreign-patient arrangements
For Tokyo Cancer Clinic, Medical Supporter should confirm current information with the clinic before referral: indication, eligibility, required documents, self-pay fees, language support, schedule and the response plan if adverse events occur after the patient returns home.
Basic information
Foreign-patient arrangements, interpreter requirements, appointment route, treatment schedule and total self-pay cost must be confirmed before travel.
Compliance reminder
Do not present dendritic-cell vaccines or immune-cell therapy as guaranteed tumor control, as recurrence prevention, or as a replacement for the patient’s oncology plan.
Official sources
Frequently Asked Questions
What are the specialties and features of Tokyo Cancer Clinic?
Tokyo Cancer Clinic is a medical institution specializing in Advanced Clinic. Key features include: Multivalent dendritic-cell vaccine and ABeVax technical background, Activated NK/NKT/gamma-delta T-cell therapy consultation, Supportive therapy and supportive-care assessment, Foreign patients require medical-coordinator confirmation, Appointment-only clinic near Kudanshita and Iidabashi, Current physicians and founder background should be described separately.
How can international patients book an appointment or second opinion at Tokyo Cancer Clinic?
International patients should first organize their records through a medical coordination agency such as Medical Supporter and confirm acceptance with the clinic. Documents, interpretation, visa support and fees are checked case by case.